Quest Diagnostics Incorporated Declares Quarterly Dividend of $0.80 (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX) declared a quarterly dividend on Tuesday, November 11th. Stockholders of record on Tuesday, January 13th will be given a dividend of 0.80 per share by the medical research company on Wednesday, January 28th. This represents a c) annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, January 13th.

Quest Diagnostics has increased its dividend by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 14 consecutive years. Quest Diagnostics has a payout ratio of 30.4% meaning its dividend is sufficiently covered by earnings. Research analysts expect Quest Diagnostics to earn $10.49 per share next year, which means the company should continue to be able to cover its $3.20 annual dividend with an expected future payout ratio of 30.5%.

Quest Diagnostics Price Performance

Shares of DGX traded down $0.44 during trading hours on Wednesday, hitting $188.41. 483,453 shares of the stock were exchanged, compared to its average volume of 1,103,310. The stock’s 50-day moving average price is $182.60 and its two-hundred day moving average price is $178.04. Quest Diagnostics has a 12-month low of $148.70 and a 12-month high of $197.55. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.04 and a current ratio of 1.13. The company has a market cap of $20.96 billion, a price-to-earnings ratio of 22.11, a price-to-earnings-growth ratio of 2.31 and a beta of 0.58.

Quest Diagnostics (NYSE:DGX) last announced its earnings results on Tuesday, October 21st. The medical research company reported $2.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.51 by $0.09. Quest Diagnostics had a net margin of 8.91% and a return on equity of 15.47%. The company had revenue of $2.82 billion for the quarter, compared to analysts’ expectations of $2.73 billion. During the same quarter in the previous year, the company posted $2.30 EPS. The firm’s quarterly revenue was up 13.2% on a year-over-year basis. Quest Diagnostics has set its FY 2025 guidance at 9.760-9.840 EPS. Research analysts expect that Quest Diagnostics will post 9.7 earnings per share for the current year.

Quest Diagnostics Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.